PeptidePedia The community reference

Special:RecentChanges

Change log·7,183 revisions·page 48 of 72

Every change to PeptidePedia Wiki, newest first. N marks a new page, m a minor edit and b an edit by an approved bot. The byte figure is the page size after the edit; the coloured figure is the change. 7,183 changes are logged in total.

7,183Logged changes
598Bot edits
175Page creations
256Active editors

24 March 2025

  1. (diff | hist) m 13:21 Sterility testing 3,636 +401 SourceHunterSile (talk | contribs) add the repeatability figure with the number of injections [rollback]
  2. (diff | hist) 08:33 Talk:Vial 1,244 +205 MergeMorwenna (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  3. (diff | hist) 06:35 PeptideMeter 3,873 +139 Retention_Time_Rae (talk | contribs) typo [rollback]
  4. (diff | hist) m 02:59 Peptide stability table 3,914 ±0 TalkPageTaro (talk | contribs) add the axis labels to the inline bar figure [rollback]
  5. (diff | hist) m 02:56 Test report forgery 4,138 +123 Retention_Time_Rae (talk | contribs) state that the sample was not drawn blind, so it represents the vial and not the lot [rollback]
  6. (diff | hist) 01:46 Peptide 4,933 ±0 CouplingCillian (talk | contribs) correct the freezer temperature range given for long-term storage [rollback]
  7. (diff | hist) 00:52 Liraglutide 4,532 ±0 SurpassSunniva (talk | contribs) expand §Clinical evidence [rollback]
  8. (diff | hist) 00:45 Lot traceability 4,002 ±0 LurkerLevi (talk | contribs) correct the description of the sampling procedure [rollback]

23 March 2025

  1. (diff | hist) m b 22:50 Retention time 3,306 ±0 ArchiveBot (talk | contribs) bot: normalise unit spacing [rollback]
  2. (diff | hist) m 15:13 Blind sampling 6,780 ±0 LotTraceLuka (talk | contribs) add the cross-link to the traceability article [rollback]
  3. (diff | hist) m b 06:31 ISO 9001 3,340 ±0 ArchiveBot (talk | contribs) bot: normalise citation format [rollback]
  4. (diff | hist) 01:12 Glucagon 5,754 ±0 UnitsUrsula (talk | contribs) state which salt form the mass in the infobox refers to [rollback]

22 March 2025

  1. (diff | hist) m 23:19 C-peptide 3,458 +208 CPeptidePaddy (talk | contribs) expand §Relevance to incretin therapy [rollback]
  2. (diff | hist) m 23:03 Personal importation policy 3,155 +121 StateBoardStace (talk | contribs) attribute the enforcement statement to the published policy [rollback]
  3. (diff | hist) 22:11 Active pharmaceutical ingredient 3,435 +567 ExenatideEzra (talk | contribs) expand §The regulatory frame [rollback]
  4. (diff | hist) 18:49 Intention-to-treat analysis 3,822 +27 ParentCatPansy (talk | contribs) give the absolute risk difference alongside the relative one [rollback]
  5. (diff | hist) m 18:36 Cost per milligram 2,147 +24 StubTagTeodor (talk | contribs) expand §Approved products [rollback]
  6. (diff | hist) m b 17:33 Bachem Holding (Suzhou) 8,993 +94 CiteBot (talk | contribs) bot: add supplier category [rollback]
  7. (diff | hist) 16:12 Peptide supply chain 6,060 ±0 CouplingCillian (talk | contribs) add the stopper material, since it affects moisture ingress [rollback]
  8. (diff | hist) 15:17 Peptide aggregation 4,377 +336 DiluentDiya (talk | contribs) correct the resolution formula — the denominator is the sum of the widths [rollback]
  9. (diff | hist) 09:28 GLP-1 receptor agonist 9,254 ±0 NeutralNikolai (talk | contribs) state which salt form the mass in the infobox refers to [rollback]
  10. (diff | hist) 08:21 Counterfeit peptide 3,878 +535 NAION_Noel (talk | contribs) British spelling per PP:MOS [rollback]
  11. (diff | hist) m 05:25 Insulin syringe unit conversion 3,664 ±0 BetaCellBoyd (talk | contribs) add the assumed syringe scale to the readout label [rollback]
  12. (diff | hist) 04:48 Loss on drying 3,735 ±0 GradientGus (talk | contribs) add the equilibration time to the gradient description [rollback]
  13. (diff | hist) m 00:26 Semaglutide 8,079 ±0 SemaglutideSasha (talk | contribs) expand §Material sold outside licensed supply [rollback]

21 March 2025

  1. (diff | hist) m 23:35 FLOW trial 3,456 +287 SurpassSunniva (talk | contribs) name the funder in the sentence, per PP:MOS [rollback]
  2. (diff | hist) m 22:08 Regulatory status by jurisdiction 3,391 +114 MolarMassMaeve (talk | contribs) add the telehealth prescribing point as attributed [rollback]
  3. (diff | hist) 16:18 Lyophilisation 19,880 +2,238 CostPerMgCory (talk | contribs) expand §Why lyophilised material tolerates ambient shipping [rollback]
  4. (diff | hist) m 10:56 Xi'an Mokemei Biotechnology 2,336 +151 SecondarySrc_Seb (talk | contribs) expand §Product range [rollback]
  5. (diff | hist) m b 09:12 VendorInvestigate 4,188 ±0 ArchiveBot (talk | contribs) bot: update parent category chain [rollback]

20 March 2025

  1. (diff | hist) 23:05 Incretin effect 5,768 +343 SatietySunniva (talk | contribs) the glucose-dependence of the insulinotropic effect deserves its own sentence [rollback]
  2. (diff | hist) m b 23:04 CagriSema 3,887 ±0 StubSorterBot (talk | contribs) bot: repair redlinked category [rollback]
  3. (diff | hist) 19:15 Enteroendocrine L cell 4,619 ±0 Chromatokid (talk | contribs) expand §Clinical significance [rollback]
  4. (diff | hist) m b 16:40 Prescribing information 3,683 +225 ArchiveBot (talk | contribs) bot: sort category members [rollback]
  5. (diff | hist) 11:07 Talk:Vial 1,033 +237 ColdChainCleo (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  6. (diff | hist) m b 09:29 Proglucagon 5,725 ±0 StubSorterBot (talk | contribs) bot: normalise citation format [rollback]
  7. (diff | hist) 08:44 Talk:Insulin syringe unit conversion 959 +73 SigFigSindri (talk | contribs) /* Rounding warning: is it original research? */ reply
  8. (diff | hist) m 08:36 Global access disparity 2,619 ±0 PatientPanelPru (talk | contribs) correct the population figure — the source gives eligible, not treated [rollback]
  9. (diff | hist) 08:22 Talk:Xi'an Mokemei Biotechnology 959 +255 Chromatokid (talk | contribs) /* Extract-derived listings need their own treatment */ reply
  10. (diff | hist) 07:19 Flourishglobal Peptide Biotech 3,594 +747 SecondarySrc_Seb (talk | contribs) expand §Ordering and availability [rollback]
  11. (diff | hist) 05:54 Subcutaneous injection 4,039 ±0 BPC_Bramwell (talk | contribs) the vial strength in the example was inconsistent between two paragraphs [rollback]

19 March 2025

  1. (diff | hist) m 23:22 Repackaging 3,958 ±0 StopperingSteff (talk | contribs) add the excursion tolerance with the study it derives from [rollback]
  2. (diff | hist) 22:54 Janoshik Analytical 4,126 ±0 COA_Colwyn (talk | contribs) add the second-opinion point: two services, one lot, is a stronger record [rollback]
  3. (diff | hist) m 21:46 Sangon Biotech 6,767 +822 ColdChainCleo (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]
  4. (diff | hist) 13:05 Talk:Insulin syringe unit conversion 748 +209 Hedgerow_Hal (talk | contribs) /* Rounding warning: is it original research? */ reply
  5. (diff | hist) 12:40 Talk:Xi'an Mokemei Biotechnology 748 +125 ChromCleanupCass (talk | contribs) /* Extract-derived listings need their own treatment */ reply
  6. (diff | hist) m b 11:14 Residual solvent 4,125 +389 CategoryBot (talk | contribs) bot: repair redlinked category [rollback]
  7. (diff | hist) 10:33 Talk:Insulin syringe unit conversion 537 +265 SigFigSindri (talk | contribs) /* Rounding warning: is it original research? */ new section
  8. (diff | hist) 09:15 Talk:Xi'an Mokemei Biotechnology 537 +298 AnalyticalAnnie (talk | contribs) /* Extract-derived listings need their own treatment */ new section
  9. (diff | hist) 09:14 Talk:Vial 822 +257 EndotoxinEd (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  10. (diff | hist) N 09:00 Xi'an Mokemei Biotechnology 2,185 +2,185 COA_Colwyn (talk | contribs) start organisation article — registry facts and product scope only

18 March 2025

  1. (diff | hist) 21:22 Nantong Guangyuan Chemical 9,618 +623 HarmReductionHen (talk | contribs) add the note that self-published material is usable only for what it states about itself [rollback]
  2. (diff | hist) 15:22 Talk:Shanghai Wibson Biotechnology 1,244 +231 DeletionDeb (talk | contribs) /* Notability: what a five-year registry history establishes */ reply
  3. (diff | hist) 13:40 Talk:Vial 611 +341 StopperingSteff (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ reply
  4. (diff | hist) 13:25 Placebo-adjusted effect 3,671 ±0 GramsNotUnitsGil (talk | contribs) attribute the subgroup finding as exploratory [rollback]
  5. (diff | hist) 10:52 Talk:Vial 400 +379 MergeMorwenna (talk | contribs) /* Merge proposal: Multi-dose vial into this article */ new section
  6. (diff | hist) 05:36 Fmoc chemistry 4,412 +694 GradientGus (talk | contribs) expand §Why the scheme matters downstream [rollback]

17 March 2025

  1. (diff | hist) 23:58 Cold-chain freight 3,699 +474 TesamorelinTeg (talk | contribs) add the collapse-temperature point, sourced [rollback]
  2. (diff | hist) 22:14 Cagrilintide 3,187 ±0 MolarMassMaeve (talk | contribs) expand §Material sold under the name [rollback]
  3. (diff | hist) 18:49 Tianjin Finder Chemical 6,613 +144 UnderfillUna (talk | contribs) add the storage and handling guidance the organisation publishes [rollback]
  4. (diff | hist) 15:41 Cold chain 20,222 +1,422 ReceptorRhoda (talk | contribs) expand §Packaging and qualification [rollback]
  5. (diff | hist) 12:56 International nonproprietary name 3,145 ±0 TirzTaxonomist (talk | contribs) give the strength per pen as well as per millilitre [rollback]
  6. (diff | hist) m 12:37 Crude peptide 3,916 +265 ColdChainCleo (talk | contribs) expand §What is in it [rollback]
  7. (diff | hist) 09:44 TRIUMPH trial programme 4,014 +519 MoveRequestMio (talk | contribs) convert the endpoint list to a table for comparability [rollback]
  8. (diff | hist) 08:37 List of GLP-1 receptor agonists 3,023 ±0 StubTagTeodor (talk | contribs) correct a wikilink that pointed at the disambiguation page [rollback]
  9. (diff | hist) m b 07:56 Reference standard 4,120 ±0 CiteBot (talk | contribs) bot: sort category members [rollback]
  10. (diff | hist) 06:44 ChinaPeptides 7,287 +274 TallySheetTad (talk | contribs) expand §Regulatory position and legal status [rollback]
  11. (diff | hist) m b 06:10 Dose escalation schedule 3,650 +18 CiteBot (talk | contribs) bot: sort category members [rollback]
  12. (diff | hist) 05:33 Guangzhou JEEP Biotechnology 10,002 +342 EndotoxinEd (talk | contribs) expand §Product range [rollback]
  13. (diff | hist) 02:59 Patent expiry and biosimilars 3,173 ±0 API_Aurora (talk | contribs) add the good-manufacturing-practice framework by name [rollback]

16 March 2025

  1. (diff | hist) m b 22:34 Weight regain after discontinuation 4,031 ±0 ArchiveBot (talk | contribs) bot: expand PMID to full citation [rollback]
  2. (diff | hist) 18:18 Melanotan II 3,391 +33 SchematicScout (talk | contribs) the sequence in the infobox was missing the C-terminal amide; added [rollback]
  3. (diff | hist) m b 10:59 Sterile water for injection 3,619 ±0 ArchiveBot (talk | contribs) bot: repair redlinked category [rollback]
  4. (diff | hist) 09:15 Talk:Flourishglobal Peptide Biotech 822 +60 NotabilityNoa (talk | contribs) /* Notability: smaller report base */ reply
  5. (diff | hist) 08:22 Good manufacturing practice 3,548 ±0 MOTSc_Mira (talk | contribs) add the note that a certificate of analysis has no regulatory standing [rollback]
  6. (diff | hist) 02:35 Fasting insulin 2,962 ±0 B12_Bettina (talk | contribs) split the analytical performance from the clinical interpretation [rollback]
  7. (diff | hist) m 01:28 Retatrutide 5,700 ±0 SemaglutideSasha (talk | contribs) expand §Material sold as retatrutide [rollback]
  8. (diff | hist) 00:40 Batch number 3,708 ±0 ChainCustodyChad (talk | contribs) British spelling per PP:MOS [rollback]

15 March 2025

  1. (diff | hist) 20:54 Resin cleavage 3,277 ±0 ColdChainCleo (talk | contribs) ce per PP:MOS [rollback]
  2. (diff | hist) 16:50 Shanghai Sigma-Audley New Material Technology 7,523 +507 COA_Colwyn (talk | contribs) add the registered legal name exactly as it appears in the registry record [rollback]
  3. (diff | hist) m 07:29 Peptide synthesis 4,113 ±0 RepackRadek (talk | contribs) state that overlay gas is used and name it [rollback]
  4. (diff | hist) 07:07 Amylin 4,252 ±0 Peptide_Pete (talk | contribs) add the molecular formula to the infobox [rollback]
  5. (diff | hist) 02:58 Aspiration risk under anaesthesia 3,880 +155 MTC_Marisol (talk | contribs) give the incidence with its denominator [rollback]
  6. (diff | hist) m 01:12 Insulin syringe 4,111 ±0 SharpsSukhi (talk | contribs) rm the titration schedule — that belongs on the compound article [rollback]
  7. (diff | hist) m 00:38 Medutest 3,795 ±0 ApoB_Aurelio (talk | contribs) fix hyphenation per PP:MOS [rollback]

14 March 2025

  1. (diff | hist) 22:39 Solid-phase peptide synthesis 5,076 +797 MissedDoseMik (talk | contribs) space between number and unit per PP:MOS [rollback]
  2. (diff | hist) m 20:07 Grey market 2,576 ±0 Ref_Desk_Ron (talk | contribs) expand §What the term does not mean [rollback]
  3. (diff | hist) m b 18:08 Shanghai Wibson Biotechnology 5,508 +192 CiteBot (talk | contribs) bot: sort category members [rollback]
  4. (diff | hist) m b 17:08 Bacteriostatic water 3,824 ±0 CiteBot (talk | contribs) bot: normalise citation format [rollback]
  5. (diff | hist) 16:42 SELECT trial 4,206 ±0 Chromatokid (talk | contribs) state the non-inferiority margin, since the design was non-inferiority [rollback]
  6. (diff | hist) 15:53 Limit of detection 3,971 ±0 ITT_Imelda (talk | contribs) state that ultraviolet response is not uniform across impurities [rollback]
  7. (diff | hist) 14:58 Area percent purity 6,569 ±0 MassSpecMarv (talk | contribs) fix hyphenation per PP:MOS [rollback]
  8. (diff | hist) 14:47 Talk:Flourishglobal Peptide Biotech 611 +165 TallySheetTad (talk | contribs) /* Notability: smaller report base */ reply
  9. (diff | hist) 11:22 Talk:Flourishglobal Peptide Biotech 400 +427 NotabilityNoa (talk | contribs) /* Notability: smaller report base */ new section
  10. (diff | hist) 06:55 Reverse-phase HPLC 4,246 ±0 Chromatokid (talk | contribs) consistent en dashes in ranges [rollback]
  11. (diff | hist) 06:41 Custom peptide synthesis 3,777 +378 DiluentDiya (talk | contribs) close an unbalanced quotation mark [rollback]
  12. (diff | hist) 06:15 Chain of custody 4,085 +169 API_Aurora (talk | contribs) clarify that a certificate is a claim by its issuer [rollback]
  13. (diff | hist) 06:13 Beyond-use date 12,094 +1,001 RotationRosalind (talk | contribs) expand §Assignment in the absence of data [rollback]
  14. (diff | hist) 05:35 Arcuate nucleus 4,321 ±0 TesamorelinTeg (talk | contribs) clarify that the receptor is expressed outside the pancreas [rollback]
  15. (diff | hist) m 00:58 Flourishglobal Peptide Biotech 2,847 +38 PriorAuthPaz (talk | contribs) clarify that a registered business scope is a licensing fact, not a quality assurance [rollback]